Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19 Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06130345
What this trial is testing

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 15,196,685
Early research (Phase 1)Study completedNCT05181709
What this trial is testing

A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

Who this might be right for
SARS-CoV-2
Sean Liu 35
Not applicableStudy completedNCT05582564
What this trial is testing

The Effect of Newspaper Reporting on COVID-19 Vaccine Hesitancy: a Randomised Controlled Trial

Who this might be right for
Vaccine Hesitancy
University of Bari Aldo Moro 1,068
Large-scale testing (Phase 3)UnknownNCT05124171
What this trial is testing

Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary Vaccination

Who this might be right for
COVID-19Vaccine Reaction
Assistance Publique - Hôpitaux de Paris 247
Not applicableStudy completedNCT05621239
What this trial is testing

Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People

Who this might be right for
COVID-19
Pfizer 260
Not applicableStudy completedNCT06297876
What this trial is testing

COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color

Who this might be right for
Vaccine Hesitancy
University of Massachusetts, Worcester 100
Not applicableStudy completedNCT04858568
What this trial is testing

Immune Responses to COVID-19 Vaccination in Lymphoma Patients

Who this might be right for
Classical Hodgkin LymphomaDiffuse Large B Cell LymphomaPrimary Mediastinal B Cell Lymphoma+10 more
University Hospital Southampton NHS Foundation Trust 592
Very early researchUnknownNCT05928468
What this trial is testing

The Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002

Who this might be right for
COVID-19
Guangzhou Patronus Biotech Co., Ltd. 210
Early research (Phase 1)Study completedNCT04765436
What this trial is testing

PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64

Who this might be right for
Covid19 Vaccine
Providence Therapeutics Holdings Inc. 60
Large-scale testing (Phase 3)UnknownNCT05602558
What this trial is testing

The Phase Ⅱ/Ⅲ Trial of LYB001

Who this might be right for
COVID-19
Yantai Patronus Biotech Co., Ltd. 18,000
Not applicableUnknownNCT04821570
What this trial is testing

To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment

Who this might be right for
Breast CancerLung CancerMelanoma (Skin)
University of Kansas Medical Center 500
Testing effectiveness (Phase 2)Study completedNCT05198102
What this trial is testing

ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

Who this might be right for
Prevention of COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Not applicableStudy completedNCT04847596
What this trial is testing

Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 25
Not applicableEnrolling By InvitationNCT07651761
What this trial is testing

Patient-Centered Practical Vaccine Talk For Busy Clinicians

Who this might be right for
InfluenzaCOVID-19
University of Massachusetts, Worcester 24,500
Post-approval studies (Phase 4)Study completedNCT04952727
What this trial is testing

Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 300
Not applicableUnknownNCT04724642
What this trial is testing

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency

Who this might be right for
Allogenic Hematopoietic Cell TransplantCAR-T TherapyPrimary Immunodeficiency
Tel-Aviv Sourasky Medical Center 110
Not applicableStudy completedNCT05384886
What this trial is testing

Impact of New Variants and Vaccines on the Course of COVID-19

Who this might be right for
COVID-19
Izmir Katip Celebi University 15,967
Post-approval studies (Phase 4)Study completedNCT04348370
What this trial is testing

BCG Vaccine for Health Care Workers as Defense Against COVID 19

Who this might be right for
CoronavirusCoronavirus InfectionCoronavirus as the Cause of Diseases Classified Elsewhere
Texas A&M University 659
Testing effectiveness (Phase 2)Study completedNCT05463354
What this trial is testing

Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd. 410
Not applicableStudy completedNCT04664023
What this trial is testing

Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution

Who this might be right for
Covid19
Poitiers University Hospital 130
Next Page